Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual Antiplatelet Therapy in Aspirin Resistant Patients Post-CABG
NCT01159639Phase 4Completed
- Sponsor
- University of Zagreb
- Start
- Jun 2010
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of clopidogrel in coronary artery disease (CAD) (2 arms), sponsored by University of Zagreb. Primary endpoint: Major Adverse Cardiac Events at 6 months. Started Jun 2010; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01159639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01159639.